Biblio Discovery — Demo Discovery Service

3 hasil untuk "Alexandre J. Debacker"

Menampilkan 1–3 · 0,53 detik · RSS

  1. Artikel Jurnal

    Delivery of Oligonucleotides to the Liver with GalNAc: From Research to Registered Therapeutic Drug

    Alexandre J. Debacker; Jon Voutila; Matthew C. Catley dkk.

    Molecular Therapy · 2020 · Inggris · OpenAlex Scopus

    Targeted delivery of oligonucleotides to liver hepatocytes using N-acetylgalactosamine (GalNAc) conjugates that bind to the asialoglycoprotein receptor has become a breakthrough approach in the therapeutic oligonucleotide field. This technology has led to the approval of givosiran for the treatment…

  2. Artikel Jurnal

    Heavily and fully modified RNAs guide efficient SpyCas9-mediated genome editing

    Aamir Mir; Julia F. Alterman; Matthew R. Hassler dkk.

    Nature Communications, Vol. 9 No. 1 · 2018 · Inggris · DOAJ Scopus

    Resistance of gRNA to ubiquitous ribonucleases is required for CRISPR-Cas9-based therapeutics. Here, the authors explore chemical modifications at all positions of the crRNA guide and tracrRNA cofactor, and identify modified versions that are more potent and stable than their unmodified…

  3. Artikel Jurnal

    Locked Nucleic Acid Gapmers and Conjugates Potently Silence ADAM33, an Asthma-Associated Metalloprotease with Nuclear-Localized mRNA

    Hannah M. Pendergraff; Pranathi Meda Krishnamurthy; Alexandre J. Debacker dkk.

    Molecular Therapy: Nucleic Acids, Vol. 8 · 2017 · Inggris · DOAJ Scopus

    Two mechanisms dominate the clinical pipeline for oligonucleotide-based gene silencing, namely, the antisense approach that recruits RNase H to cleave target RNA and the RNAi approach that recruits the RISC complex to cleave target RNA. Multiple chemical designs can be used to elicit each pathway…